Access cutting-edge lung cancer treatment through this clinical trial at a research site in Fairbanks. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Fairbanks at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes can
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this lung cancer clinical trial in Fairbanks, AK
If you're searching for lung cancer treatment options in Fairbanks, AK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fairbanks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.